Innovative Designs and Analyses for Small Population Clinical Trials: Development Strategies and Operational Engagement for Pediatric and Rare Diseases - Rilegato

Nie, Lei; Ye, Jingjing

Rilegato

ISBN 10: 3031608429 ISBN 13: 9783031608421

Casa editrice: Springer Nature, 2024

Riassunto

This book discusses a multidisciplinary and multi-stakeholder collaborative approach to small population clinical trials. It provides and illustrates a systematic framework that depends upon a collaborative infrastructure between the patient community, patient advocacy groups, researchers and investigators, pharmaceutical companies, global regulatory agencies, and customers. The book also highlights the considerations of natural history and patient registry, diagnostic criteria determination, identification of clinically meaningful endpoints, and global regulatory guidance. The authors detail the nuances of clinical trial design as specific to small population disease, drawing from real examples.

Su questo libro

Informazioni sull'autore

?

Jingjing Ye is Senior Director, Head of Data Science of Operational Excellence (DSOE) in Global Statistics and Data Science (GSDS). She leads a team to promote innovations in various organizations within BeiGene. She has been active in the scientific community, serving as an FDA representative between industry leaders, academic institutions, and the FDA on various scientific working groups, including pediatric, external controls in oncology, simulation in adaptive designs, and quantitative imaging biomarkers. She currently leads several cross-disciplinary working groups, including ASA Biopharmaceutical (BIOP) Section Pediatric Working Group, ASA-DIA Master Protocol and DIA Data Sciences.
Lei Nie is the Associate Division Director for DB II, in the US Food & Drug Administraion. He is an elected fellow of the American Statistical Association and has authored a total of 99 peer-reviewed journal publications. Passionate about multidisciplinary collaboration and the important work performed at the FDA, he always looks for ways to improve efficiencies and to maintain a good work-family balance.

Dalla quarta di copertina

This book discusses a multidisciplinary and multi-stakeholder collaborative approach to small population clinical trials. It provides and illustrates a systematic framework that depends upon a collaborative infrastructure between the patient community, patient advocacy groups, researchers and investigators, pharmaceutical companies, global regulatory agencies, and customers. The book also highlights the considerations of natural history and patient registry, diagnostic criteria determination, identification of clinically meaningful endpoints, and global regulatory guidance. The authors detail the nuances of clinical trial design as specific to small population disease, drawing from real examples.

Dettagli dell'edizione

• Editore: Springer Nature
• Data di pubblicazione: 2024
• Lingua: Inglese
• ISBN 10: 3031608429
• ISBN 13: 9783031608421
• Rilegatura: Copertina rigida
• Numero di pagine: 350
• Contatto del produttore: Springer Nature Customer Service Center GmbH; ProductSafety@springernature.com; ; Europaplatz 3; Heidelberg; 69115; Germania